Filing Details
- Accession Number:
- 0001209191-20-037769
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-06-18 21:45:29
- Reporting Period:
- 2020-06-17
- Accepted Time:
- 2020-06-18 21:45:29
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1501756 | Adverum Biotechnologies Inc. | ADVM | Biological Products, (No Disgnostic Substances) (2836) | 205258327 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1614875 | Mehdi Gasmi | C/O Adverum Biotechnologies, Inc. 800 Saginaw Drive Redwood City CA 94063 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-06-17 | 268 | $4.80 | 274,710 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-06-17 | 268 | $25.01 | 274,442 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2020-06-18 | 11,127 | $4.80 | 285,569 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-06-18 | 11,127 | $25.01 | 274,442 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2020-06-17 | 268 | $0.00 | 268 | $4.80 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2020-06-18 | 11,127 | $0.00 | 11,127 | $4.80 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 117,732 | 2026-02-11 | No | 4 | M | Direct | |
| 106,605 | 2026-02-11 | No | 4 | M | Direct |
Footnotes
- Shares sold pursuant to a 10b5-1 plan.
- Price reported is a weighted-average sales price. The shares were sold at prices ranging from $25.00 to $25.04. The reporting person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- Price reported is a weighted-average sales price. The shares were sold at prices ranging from $25.00 to $25.05. The reporting person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- Fully vested and exercisable.
Billionaire Hedge Funds
